Sword Health Raises $40M at $4B Valuation, Delays IPO to 2028

Sword Health secures $40M at a $4B valuation and delays IPO to 2028 to expand AI healthcare across multiple verticals.
Matilda
Sword Health Raises $40M at $4B Valuation, Delays IPO to 2028
Sword Health $40M Funding: Why the Digital Health Giant Is Delaying Its IPO to 2028 Sword Health has just raised $40 million in fresh funding, boosting its valuation to $4 billion — a 33% increase from last year. This funding round, led by returning investor General Catalyst, has not only drawn attention due to the financial milestone but also because of the startup's decision to push its IPO plans to at least 2028. If you’ve been wondering why a profitable, fast-growing digital health company like Sword Health would delay going public, you’re not alone. Let’s break down the reasoning behind the Sword Health $40M funding, the company’s evolving healthcare vision, and what this all means for the future of AI-powered medicine.                              Image Credits:Sword Health Why Sword Health Raised $40M Despite Being Cash-Flow Positive While many startups raise capital out of necessity, Sword Health took a more strategic route. Founder and CEO Virgílio Bento explained that the pr…